Below are the financial statements of Merck KGaA, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of EUR | 2024 | 2023 |
|---|---|---|
| Net sales | 21,156a | 20,993a |
| Cost of sales | -8,671a | -8,600a |
| Gross profit | 12,485a | 12,392a |
| Marketing and selling expenses | -4,536a | -4,510a |
| Administration expenses | -1,370a | -1,392a |
| Research and development costs | -2,279a | -2,445a |
| Impairment losses and reversals of impairment losses on financial assets (net) | -8a | -51a |
| Other operating income | 269a | 445a |
| Other operating expenses | -915a | -830a |
| Operating result (EBIT) | 3,645a | 3,609a |
| Finance income | 200a | 197a |
| Finance costs | -309a | -322a |
| Profit before income tax | 3,536a | 3,484a |
| Income tax | -751a | -650a |
| Profit after tax | 2,786a | 2,834a |
| Thereof: attributable to Merck KGaA shareholders (net income) | 2,777a | 2,824a |
| Thereof: attributable to non-controlling interests | 9a | 10a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Merck KGaA’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.